Description
A fungal metabolite; inhibits yeast α-glucosidase in vitro (IC50 = 383.2 μM); decreases plasma glucose levels in mice after administration of sucrose (3.1-31.6 mg/kg); decreases the plasma glucose postprandial peak in nicotinamide-streptozotocin-induced hyperglycemic mice (10 mg/kg); antagonist of NK1 receptors (Kis = 12, 42, and 43 μM for guinea pig, rat, and human receptors, respectively)
Formal name: (6S,7S)-6,7-dihydro-6-methyl-7-(phenylmethyl)-quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione
Synonyms: (-)-Benzomalvin A
Molecular weight: 381.4
CAS: 157047-96-6
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Natural Products|Microbial Metabolites||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Neuroscience